Auftragserfassung
Switzerland
AuftragsverfolgungKontakt
 

DAPT ≥98% (durch NMR)

Anbieter:   Enzo Life Sciences
DAPT ≥98% (durch NMR)
Anbieter:  Enzo Life Sciences
Zertifikate
DAPT ≥98% (durch NMR)

2 Varianten

Product Details & Documents

gamma-Secretase inhibitor

Cell permeable inhibitor of γ-secretase (IC50=115nM for total β-amyloid, IC50=200 nM for β-amyloid 1-42). It reduces Aβ levels in vivo in plasma and cerebrospinal fluid in young and aged Tg2576 mice. It blocks the proteolytic processing of neurotrophin receptor alike death domain protein (NRADD)Does not inhibit presenilinase. Antagonizes Notch signaling through inhibition of Notch processing. DAPT treatment can influence hematopoietic cell fate decisions and enhances neuronal differentiation in embryonic stem cell-derived embryoid bodies independent of sonic hedgehog (shh) signaling.

Synonyme:  N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-Butyl Ester, tert-Butyl (S)-2-((S)-2-(2-(3,5-difluorophenyl)acetamido)propanamido)-2-phenylacetate, (3,5-Difluorophenylacetyl)-Ala-Phg-OtBu, (3,5-Difluorophenylacetyl)-L-alanyl-L-2-phenylglycine tert-Butyl Ester
  • CAS Nummer:208255-80-5
  • Formel:C₂₃H₂₆F₂N₂O₄
  • MDL-Nummer:MFCD04974585
  • Molekulargewicht:432.47 g/mol
Product Family Options

Produktinformationen